scispace - formally typeset
S

Sebastien Andre Campos

Researcher at GlaxoSmithKline

Publications -  42
Citations -  1583

Sebastien Andre Campos is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Ubiquitin ligase & Kinase. The author has an hindex of 18, co-authored 39 publications receiving 1231 citations. Previous affiliations of Sebastien Andre Campos include University College London & University of Hertfordshire.

Papers
More filters
Patent

Compounds&methods for the enhanced degradation of targeted proteins&other polypeptides by an e3 ubiquitin ligase

TL;DR: In this paper, a broad range of pharmacological activities associated with compounds according to the present invention, consistent with the degradation/inhibition of targeted polypeptides, are described.
Journal ArticleDOI

Spectroscopic studies of Yb3+-doped rare earth orthosilicate crystals

TL;DR: In this paper, the energy levels of the Yb3+ ion 2F5/2 manifold were analyzed in the same C2h6 crystallographic space group and it was shown that Yb 3+ ions experience high crystal field strength, particularly in Yb:SSO.
Journal ArticleDOI

Selectively targeting the kinome-conserved lysine of PI3Kδ as a general approach to covalent kinase inhibition

TL;DR: A novel approach to achieve selective, irreversible kinase inhibition, by targeting the conserved catalytic lysine residue, by developing selective, covalent PI3Kδ inhibitors that exhibit nanomolar potency in cellular assays, and a duration of action >48 h in CD4+ T cells.
Journal ArticleDOI

Site-selective deuteration of N-heterocycles via iridium-catalyzed hydrogen isotope exchange

TL;DR: The application of iridium(I) NHC/phosphine catalysts has delivered highly selective deuteration of indole, azaindole, and pyrrole N-heterocycles, which represent an important and relatively underexplored class of labeling substrates.